To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
Clinical trial NCT05740917 · UNKNOWN
Trial details
- NCT number
- NCT05740917
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-02-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.